Alternative Treatments for Multiple Myeloma
Links shared publicly online about this topic
Multiple myeloma : The Lancet
thelancet.com — “Multiple myeloma. By - Marc S Raab MD, Klaus Podar MD, Iris Breitkreutz MD, Paul G Richardson MD, Prof Kenneth C Anderson MD” View full resource at thelancet.com
Most Recently Shared on June 26, 2009 at 7:03 pm By:
Multiple Myeloma and Multiple Myeloma Treatment - MD Anderson Cancer Center
mdanderson.org — “Information on multiple myeloma, risk factors, symptoms, diagnosis and treatment options.” View full resource at mdanderson.org
Most Recently Shared on March 28, 2011 at 2:33 pm By:
Geraldine Ferraro died of multiple myeloma this weekend. Are you familiar w/these 5 symptoms of the disease? http://bit.ly/dOK5Fv
Oncology Article | multiple myeloma
mdlinx.com — “Monoclonal antibodies in the treatment of multiple myeloma” View full resource at mdlinx.com
Most Recently Shared on July 25, 2011 at 12:18 pm By:
Monoclonal antibodies in the treatment of multiple myeloma: British Journal of Haematology http://bit.ly/nzIKAN #oncology
Multiple Myeloma on #MDlinx
mdlinx.com — “Multiple Myeloma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 25, 2010 at 4:55 pm By:
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues: The Lancet Oncology... http://bit.ly/bnn4O1 #oncology
Multiple Myeloma on #MDlinx
mdlinx.com — “Multiple Myeloma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 26, 2010 at 6:59 am By:
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues: The Lancet Oncology - ... http://bit.ly/bqd37d #neuro
Multiple Myeloma on #MDlinx
mdlinx.com — “Multiple Myeloma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 23, 2010 at 7:15 pm By:
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues: The Lancet Oncology ... http://bit.ly/9EhPGP #Nursing
Oncology Article | multiple myeloma
mdlinx.com — “Extramedullary intracranial localization of multiple myeloma and treatment with novel agents” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 2:36 pm By:
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: Cancer http://t.co/tpe9Wxg #oncology
Neurology Article | multiple myeloma
mdlinx.com — “Extramedullary intracranial localization of multiple myeloma and treatment with novel agents” View full resource at mdlinx.com
Most Recently Shared on September 9, 2011 at 7:27 pm By:
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: Cancer http://t.co/QUnqLsY #neuro
Oncology Article | multiple myeloma
mdlinx.com — “Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings” View full resource at mdlinx.com
Most Recently Shared on July 11, 2011 at 12:17 pm By:
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for... http://bit.ly/ouqxwc #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): A randomised controlled trial” View full resource at mdlinx.com
Most Recently Shared on December 9, 2010 at 5:44 am By:
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Mye... http://bit.ly/eLtnCQ #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers” View full resource at mdlinx.com
Most Recently Shared on January 21, 2011 at 12:13 pm By:
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and... http://bit.ly/i6Rkhj #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: Results of a phase 1/2 study” View full resource at mdlinx.com
Most Recently Shared on May 2, 2011 at 1:39 pm By:
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory... http://bit.ly/iBXhew #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma” View full resource at mdlinx.com
Most Recently Shared on February 25, 2011 at 6:49 am By:
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases... http://bit.ly/fvLZZt #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach” View full resource at mdlinx.com
Most Recently Shared on September 9, 2011 at 8:56 am By:
Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Tre... http://t.co/HBXwAdx #oncology
Oncology Article | multiple myeloma
mdlinx.com — “Reduction in plasma cell proliferation following initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival” View full resource at mdlinx.com
Most Recently Shared on July 15, 2011 at 5:13 pm By:
Reduction in plasma cell proliferation following initial therapy in newly diagnosed multiple myeloma m... http://bit.ly/pyXyrh #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
M Auron MD
Internist and Pediatrician. Hospitalist.
-
Focused on Health
Focused on Health is MD Anderson Cancer Center's monthly newsletter featuring news and tips on healthy living and cancer prevention.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

